Litigation Details for Pharmacyclics LLC v. Hetero USA Inc. (D. Del. 2018)
✉ Email this page to a colleague
Pharmacyclics LLC v. Hetero USA Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-11-12 |
| Court | District Court, D. Delaware | Date Terminated | 2019-02-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 8,754,090; 9,296,753; 9,540,382; 9,713,617; 9,725,455 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pharmacyclics LLC v. Hetero USA Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Pharmacyclics LLC v. Hetero USA Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-11-12 | 1 | United States Patent Nos. 8,754,090 (“the ’090 Patent”); 9,296,753 (“the ’753 Patent”); 9,540,382 (“…(“the ’382 Patent”); 9,713,617 (“the ’617 Patent”); and 9,725,455 (“the ’455 Patent”). Case 1:18-cv… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…22. This civil action for patent infringement arises under the patent laws of the United States, including… THE ASSERTED PATENTS 37. The ’090 Patent, entitled “Use of Inhibitors of | External link to document | |
| 0000-00-00 | 14 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,754,090 B2; 9,296,753 B2; 9,540,382… 12 February 2019 1:18-cv-01778 835 Patent - Abbreviated New Drug Application(ANDA) | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
